Key Points
-
Invasive Salmonella disease comprises enteric fever (caused by Salmonella enterica subsp. enterica serovar Typhi and S. enterica serovars Paratyphi A, B and C) and invasive non-typhoidal Salmonella (iNTS) disease (caused by NTS serovars, most notably S. enterica serovar Typhimurium and S. enterica serovar Enteritidis). Both diseases impose a substantial burden of morbidity and mortality globally, for which adequate control measures are lacking.
-
In this Review, we discuss data from population-based studies of enteric fever and primary immunodeficiencies resulting in susceptibility to iNTS disease. These studies are presented in the context of the well-defined mouse model of invasive Salmonella infection.
-
The study of primary immunodeficiencies, in part characterized by iNTS disease, has established the critical role of interferon-γ (IFNγ) production and IFNγ-induced effector mechanisms (in particular oxidative burst) in human immunity to NTS. These studies have helped to define the role of T helper 1 (TH1) cells in mediating the outcome of intracellular NTS infection, and have been complemented by more recent data describing the roles of TH17 lineage CD4+ T cells and neutrophils in human NTS immunity.
-
The recent publication of the first genome-wide association study of invasive Salmonella disease provides robust evidence for a host genetic determinant of enteric fever in human populations. Its identification of an MHC class II allele as a determinant of enteric fever susceptibility is in keeping with our broader understanding of immunity against Salmonella from the mouse model and human primary immunodeficiencies.
-
Our increasing understanding of the host genetic determinants of iNTS disease and enteric fever is improving our understanding of the immunobiology of invasive Salmonella infection and will inform the delivery of novel control strategies.
Abstract
Invasive Salmonella disease, in the form of enteric fever and invasive non-typhoidal Salmonella (iNTS) disease, causes substantial morbidity and mortality in children and adults in the developing world. The study of genetic variations in humans and mice that influence susceptibility of the host to Salmonella infection provides important insights into immunity to Salmonella. In this Review, we discuss data that have helped to elucidate the host genetic determinants of human enteric fever and iNTS disease, alongside data from the mouse model of Salmonella infection. Considered together, these studies provide a detailed picture of the immunobiology of human invasive Salmonella disease.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Change history
28 August 2015
In the original version of this article, the credit line in the legend of Figure 1 was incorrect and should read: “Copyright 2014 from 'Vaccines against invasive Salmonella disease: current status and future directions' by MacLennan, C. A., Martin, L. B. & Micoli, F. Reproduced by permission of Taylor & Francis LLC (http://www.tandfonline.com).”. This has now been corrected online.
References
Wain, J., Hendriksen, R. S., Mikoleit, M. L., Keddy, K. H. & Ochiai, R. L. Typhoid fever. Lancet 385, 1136–1145 (2015).
MacLennan, C. A. & Levine, M. M. Invasive nontyphoidal Salmonella disease in Africa: current status. Expert Rev. Anti Infect. Ther. 11, 443–446 (2013).
Crump, J. A., Luby, S. P. & Mintz, E. D. The global burden of typhoid fever. Bull. World Health Organ. 82, 346–353 (2004).
Reddy, E. A., Shaw, A. V. & Crump, J. A. Community-acquired bloodstream infections in Africa: a systematic review and meta-analysis. Lancet Infect. Dis. 10, 417–432 (2010).
Sørensen, T. I., Nielsen, G. G., Andersen, P. K. & Teasdale, T. W. Genetic and environmental influences on premature death in adult adoptees. N. Engl. J. Med. 318, 727–732 (1988). An adoptee study providing evidence for the heritability of risk of death from infectious diseases.
Dunstan, S. J. et al. Variation at HLA-DRB1 is associated with resistance to enteric fever. Nat. Genet. 46, 1333–1336 (2014). The first GWAS of invasive Salmonella disease.
Malaria Genomic Epidemiology Network. Reappraisal of known malaria resistance loci in a large multicenter study. Nat. Genet. 46, 1197–1204 (2014).
Khor, C. C. et al. CISH and susceptibility to infectious diseases. N. Engl. J. Med. 362, 2092–2101 (2010).
Khor, C. C. et al. A Mal functional variant is associated with protection against invasive pneumococcal disease, bacteremia, malaria and tuberculosis. Nat. Genet. 39, 523–528 (2007).
Santos, R. L. et al. Animal models of Salmonella infections: enteritis versus typhoid fever. Microbes Infect. 3, 1335–1344 (2001).
Hormaeche, C. E. Natural resistance to Salmonella typhimurium in different inbred mouse strains. Immunology 37, 311–318 (1979).
Hormaeche, C. E., Mastroeni, P., Arena, A., Uddin, J. & Joysey, H. S. T cells do not mediate the initial suppression of a Salmonella infection in the RES. Immunology 70, 247–250 (1990).
Hess, J., Ladel, C., Miko, D. & Kaufmann, S. H. Salmonella typhimurium aroA- infection in gene-targeted immunodeficient mice: major role of CD4+ TCR-αβ cells and IFNγ in bacterial clearance independent of intracellular location. J. Immunol. 156, 3321–3326 (1996).
Poltorak, A. et al. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 282, 2085–2088 (1998). This paper identified a missense mutation in Tlr4 as the Salmonella -susceptibility and LPS-hyporesponsiveness risk allele at Lps.
Broz, P. et al. Caspase-11 increases susceptibility to Salmonella infection in the absence of caspase-1. Nature 490, 288–291 (2013).
Muotiala, A. & Mäkelä, P. H. The role of IFN-γ in murine Salmonella typhimurium infection. Microb. Pathog. 8, 135–141 (1990).
Mastroeni, P. et al. Serum TNFα in mouse typhoid and enhancement of a Salmonella infection by anti-TNFα antibodies. Microb. Pathog. 11, 33–38 (1991).
Mastroeni, P. et al. Antimicrobial actions of the NADPH phagocyte oxidase and inducible nitric oxide synthase in experimental salmonellosis. II. Effects on microbial proliferation and host survival in vivo. J. Exp. Med. 192, 237–248 (2000).
Vidal, S. et al. The Ity/Lsh/Bcg locus: natural resistance to infection with intracellular parasites is abrogated by disruption of the Nramp1 gene. J. Exp. Med. 182, 655–666 (1995). A study identifying Slc11a1 as the Ity Salmonella -susceptibility locus in inbred mice.
Kawai, T. & Akira, S. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity. Immunity 34, 637–650 (2011).
Robson, H. G. & Vas, S. I. Resistance of inbred mice to Salmonella typhimurium. J. Infect. Dis. 126, 378–386 (1972).
Weiss, D. S., Raupach, B., Takeda, K., Akira, S. & Zychlinsky, A. Toll-like receptors are temporally involved in host defense. J. Immunol. 172, 4463–4469 (2004).
Feuillet, V. et al. Involvement of Toll-like receptor 5 in the recognition of flagellated bacteria. Proc. Natl Acad. Sci. USA 103, 12487–12492 (2006).
Arpaia, N. et al. TLR signaling is required for Salmonella typhimurium virulence. Cell 144, 675–688 (2011).
Sivick, K. E. et al. Toll-like receptor-deficient mice reveal how innate immune signaling influences Salmonella virulence strategies. Cell Host Microbe 15, 203–213 (2014).
Hanson, E. P. et al. Hypomorphic nuclear factor-κB essential modulator mutation database and reconstitution system identifies phenotypic and immunologic diversity. J. Allergy Clin. Immunol. 122, 1169–1193 (2008).
Janssen, R. et al. The same IκBα mutation in two related individuals leads to completely different clinical syndromes. J. Exp. Med. 200, 559–568 (2004).
Filipe-Santos, O. et al. X-linked susceptibility to mycobacteria is caused by mutations in NEMO impairing CD40-dependent IL-12 production. J. Exp. Med. 203, 1745–1759 (2006).
Picard, C., Casanova, J. L. & Puel, A. Infectious diseases in patients with IRAK-4, MyD88, NEMO, or IκBα deficiency. Clin. Microbiol. Rev. 24, 490–497 (2011).
Ferwerda, B. et al. Functional and genetic evidence that the Mal/TIRAP allele variant 180L has been selected by providing protection against septic shock. Proc. Natl Acad. Sci. USA 106, 10272–10277 (2009).
Bhuvanendran, S. et al. Toll-like receptor 4 Asp299Gly and Thr399Ile polymorphisms and typhoid susceptibility in Asian Malay population in Malaysia. Microbes Infect. 13, 844–851 (2011).
Hue, N. T. et al. Toll-like receptor 4 (TLR4) and typhoid fever in vietnam. PLoS ONE 4, e4800 (2009).
Dunstan, S. J. et al. Host susceptibility and clinical outcomes in toll-like receptor 5-deficient patients with typhoid fever in Vietnam. J. Infect. Dis. 191, 1068–1071 (2005).
Broz, P. et al. Redundant roles for inflammasome receptors NLRP3 and NLRC4 in host defense against Salmonella. J. Exp. Med. 207, 1745–1755 (2010).
Kayagaki, N. et al. Noncanonical inflammasome activation by intracellular LPS independent of TLR4. Science 341, 1246–1249 (2013).
Franchi, L., Warner, N., Viani, K. & Núñez, G. Function of Nod-like receptors in microbial recognition and host defense. Immunol. Rev. 227, 106–128 (2009).
Raupach, B., Peuschel, S. K., Monack, D. M. & Zychlinsky, A. Caspase-1-mediated activation of interleukin-1β (IL-1β) and IL-18 contributes to innate immune defenses against Salmonella enterica serovar Typhimurium infection. Infect. Immun. 74, 4922–4926 (2006).
Ali, S. et al. Polymorphisms in proinflammatory genes and susceptibility to typhoid fever and paratyphoid fever. J. Interferon Cytokine Res. 27, 271–280 (2007).
Conlan, J. W. Neutrophils prevent extracellular colonization of the liver microvasculature by Salmonella typhimurium. Infect. Immun. 64, 1043–1047 (1996).
Cunnington, A. J., de Souza, J. B., Walther, M. & Riley, E. M. Malaria impairs resistance to Salmonella through heme- and heme oxygenase-dependent dysfunctional granulocyte mobilization. Nat. Med. 18, 120–127 (2012).
Cunnington, A. J. et al. Prolonged neutrophil dysfunction after Plasmodium falciparum malaria is related to hemolysis and heme oxygenase-1 induction. J. Immunol. 189, 5336–5346 (2012).
Kawai, T., Adachi, O., Ogawa, T., Takeda, K. & Akira, S. Unresponsiveness of MyD88-deficient mice to endotoxin. Immunity 11, 115–122 (1999).
Mastroeni, P., Harrison, J. A., Chabalgoity, J. A. & Hormaeche, C. E. Effect of interleukin 12 neutralization on host resistance and γ interferon production in mouse typhoid. Infect. Immun. 64, 189–196 (1996).
Mastroeni, P. et al. Interleukin-12 is required for control of the growth of attenuated aromatic-compound-dependent salmonellae in BALB/c mice: role of gamma interferon and macrophage activation. Infect. Immun. 66, 4767–4776 (1998).
Kupz, A. et al. Contribution of Thy1+ NK cells to protective IFN-γ production during Salmonella typhimurium infections. Proc. Natl Acad. Sci. USA 110, 2252–2257 (2013).
Newport, M. J. et al. A mutation in the interferon-γ-receptor gene and susceptibility to mycobacterial infection. N. Engl. J. Med. 335, 1941–1949 (1996).
Dorman, S. E. et al. Clinical features of dominant and recessive interferon γ receptor 1 deficiencies. Lancet 364, 2113–2121 (2004).
Prando, C. et al. Inherited IL-12p40 deficiency: genetic, immunologic, and clinical features of 49 patients from 30 kindreds. Medicine (Baltimore) 92, 109–122 (2013).
de Beaucoudrey, L. et al. Revisiting human IL-12Rβ1 deficiency. Medicine (Baltimore) 89, 381–402 (2010). References 47–49 are large international studies defining the clinical spectrum of IFNγR1, IL-12p40 and IL-12Rβ1 deficiencies.
Averbuch, D., Chapgier, A., Boisson-Dupuis, S., Casanova, J.-L. & Engelhard, D. The clinical spectrum of patients with deficiency of signal transducer and activator of transcription-1. Pediatr. Infect. Dis. J. 30, 352–355 (2011).
Minegishi, Y. et al. Human tyrosine kinase 2 deficiency reveals its requisite roles in multiple cytokine signals involved in innate and acquired immunity. Immunity 25, 745–755 (2006).
Browne, S. K. et al. Adult-onset immunodeficiency in Thailand and Taiwan. N. Engl. J. Med. 367, 725–734 (2012).
Jong, R. D. Severe mycobacterial and Salmonella infections in interleukin-12 receptor-deficient patients. Science 280, 1435–1438 (1998).
Jouanguy, E. et al. In a novel form of IFN-γ receptor 1 deficiency, cell surface receptors fail to bind IFN-γ. J. Clin. Invest. 105, 1429–1436 (2000).
Ohmori, Y., Schreiber, R. D. & Hamilton, T. A. Synergy between interferon-γ and tumor necrosis factor-α in transcriptional activation is mediated by cooperation between signal transducer and activator of transcription 1 and nuclear factor κB. J. Biol. Chem. 272, 14899–14907 (1997).
Everest, P., Roberts, M. & Dougan, G. Susceptibility to Salmonella typhimurium infection and effectiveness of vaccination in mice deficient in the tumor necrosis factor α p55 receptor. Infect. Immun. 66, 3355–3364 (1998).
Peña-Sagredo, J. L. et al. Non-typhi Salmonella infection in patients with rheumatic diseases on TNF-α antagonist therapy. Clin. Exp. Rheumatol. 27, 920–925 (2009).
Bassetti, M., Nicco, E., Delfino, E. & Viscoli, C. Disseminated Salmonella paratyphi infection in a rheumatoid arthritis patient treated with infliximab. Clin. Microbiol. Infect. 16, 84–85 (2010).
Dunstan, S. J. et al. A TNF region haplotype offers protection from typhoid fever in Vietnamese patients. Hum. Genet. 122, 51–61 (2007).
MacMicking, J. D. Interferon-inducible effector mechanisms in cell-autonomous immunity. Nat. Rev. Immunol. 12, 367–382 (2012).
Kagaya, K., Watanabe, K. & Fukazawa, Y. Capacity of recombinant gamma interferon to activate macrophages for Salmonella-killing activity. Infect. Immun. 57, 609–615 (1989).
Khan, R. T., Yuki, K. E. & Malo, D. Fine-mapping and phenotypic analysis of the Ity3 Salmonella susceptibility locus identify a complex genetic structure. PLoS ONE 9, e88009 (2014).
Segal, B. H., Leto, T. L., Gallin, J. I., Malech, H. L. & Holland, S. M. Genetic, biochemical, and clinical features of chronic granulomatous disease. Medicine (Baltimore) 79, 170–200 (2000).
Winkelstein, J. A. et al. Chronic granulomatous disease. Report on a national registry of 368 patients. Medicine (Baltimore) 79, 155–169 (2000).
Williams, T. N. et al. Bacteraemia in Kenyan children with sickle-cell anaemia: a retrospective cohort and case-control study. Lancet 374, 1364–1370 (2009).
Mabey, D. C., Brown, A. & Greenwood, B. M. Plasmodium falciparum malaria and Salmonella infections in Gambian children. J. Infect. Dis. 155, 1319–1321 (1987).
Wanachiwanawin, W. Infections in E-β thalassemia. J. Pediatr. Hematol. Oncol. 22, 581–587 (2000).
Roy, M.-F. et al. Pyruvate kinase deficiency confers susceptibility to Salmonella typhimurium infection in mice. J. Exp. Med. 204, 2949–2961 (2007).
Ampel, N. M., Van Wyck, D. B., Aguirre, M. L., Willis, D. G. & Popp, R. A. Resistance to infection in murine β-thalassemia. Infect. Immun. 57, 1011–1017 (1989).
Yuki, K. E. et al. Suppression of hepcidin expression and iron overload mediate Salmonella susceptibility in ankyrin 1 ENU-induced mutant. PLoS ONE 8, e55331 (2013).
Hooke, W., Kaye, D. & Gill, F. A. Factors influencing host resistance to Salmonella infection. The effects of hemolysis and erythrophagocytosis. Trans. Am. Clin. Climatol. Assoc. 78, 230–241 (1967).
Govoni, G., Gauthier, S., Billia, F., Iscove, N. N. & Gros, P. Cell-specific and inducible Nramp1 gene expression in mouse macrophages in vitro and in vivo. J. Leukoc. Biol. 62, 277–286 (1997).
Jabado, N. et al. Natural resistance to intracellular infections: natural resistance-associated macrophage protein 1 (Nramp1) functions as a pH-dependent manganese transporter at the phagosomal membrane. J. Exp. Med. 192, 1237–1248 (2000).
Fritsche, G., Nairz, M., Libby, S. J., Fang, F. C. & Weiss, G. Slc11a1 (Nramp1) impairs growth of Salmonella enterica serovar Typhimurium in macrophages via stimulation of lipocalin-2 expression. J. Leukoc. Biol. 92, 353–359 (2012).
Nairz, M. et al. Absence of functional Hfe protects mice from invasive Salmonella enterica serovar Typhimurium infection via induction of lipocalin-2. Blood 114, 3642–3651 (2009).
Cairo, G. et al. Inappropriately high iron regulatory protein activity in monocytes of patients with genetic hemochromatosis. Blood 89, 2546–2553 (1997).
Dunstan, S. J. et al. Typhoid fever and genetic polymorphisms at the natural resistance-associated macrophage protein 1. J. Infect. Dis. 183, 1156–1160 (2001).
Birmingham, C. L., Smith, A. C., Bakowski, M. A., Yoshimori, T. & Brumell, J. H. Autophagy controls Salmonella infection in response to damage to the Salmonella-containing vacuole. J. Biol. Chem. 281, 11374–11383 (2006).
Conway, K. L. et al. Atg16l1 is required for autophagy in intestinal epithelial cells and protection of mice from Salmonella infection. Gastroenterology 145, 1347–1357 (2013).
Ali, S. et al. PARK2/PACRG polymorphisms and susceptibility to typhoid and paratyphoid fever. Clin. Exp. Immunol. 144, 425–431 (2006).
Liang-Takasaki, C. J., Saxén, H., Mäkelä, P. H. & Leive, L. Complement activation by polysaccharide of lipopolysaccharide: an important virulence determinant of salmonellae. Infect. Immun. 41, 563–569 (1983).
Warren, J. et al. Increased susceptibility of C1q-deficient mice to Salmonella enterica serovar Typhimurium infection. Infect. Immun. 70, 551–557 (2002).
Johnston, R. B., Newman, S. L. & Struth, A. G. An abnormality of the alternate pathway of complement activation in sickle-cell disease. N. Engl. J. Med. 288, 803–808 (1973).
Ross, S. C. & Densen, P. Complement deficiency states and infection: epidemiology, pathogenesis and consequences of neisserial and other infections in an immune deficiency. Medicine (Baltimore) 63, 243–273 (1984).
MacLennan, C. A. et al. The neglected role of antibody in protection against bacteremia caused by nontyphoidal strains of Salmonella in African children. J. Clin. Invest. 118, 1553–1562 (2008).
Sinha, K., Mastroeni, P., Harrison, J., de Hormaeche, R. D. & Hormaeche, C. E. Salmonella typhimurium aroA, htrA, and aroD htrA mutants cause progressive infections in athymic (nu/nu) BALB/c mice. Infect. Immun. 65, 1566–1569 (1997).
Lee, S.-J., Dunmire, S. & McSorley, S. J. MHC class-I-restricted CD8 T cells play a protective role during primary Salmonella infection. Immunol. Lett. 148, 138–143 (2012).
Mastroeni, P., Villarreal-Ramos, B. & Hormaeche, C. E. Role of T cells, TNFα and IFNγ in recall of immunity to oral challenge with virulent salmonellae in mice vaccinated with live attenuated aro− Salmonella vaccines. Microb. Pathog. 13, 477–491 (1992).
Mastroeni, P., Simmons, C., Fowler, R., Hormaeche, C. E. & Dougan, G. Igh-6−/− (B-cell-deficient) mice fail to mount solid acquired resistance to oral challenge with virulent Salmonella enterica serovar Typhimurium and show impaired Th1 T-cell responses to Salmonella antigens. Infect. Immun. 68, 46–53 (2000).
MacLennan, C. et al. Interleukin (IL)-12 and IL-23 are key cytokines for immunity against Salmonella in humans. J. Infect. Dis. 190, 1755–1757 (2004).
de Beaucoudrey, L. et al. Mutations in STAT3 and IL12RB1 impair the development of human IL-17-producing T cells. J. Exp. Med. 205, 1543–1550 (2008).
Raffatellu, M. et al. Simian immunodeficiency virus-induced mucosal interleukin-17 deficiency promotes Salmonella dissemination from the gut. Nat. Med. 14, 421–428 (2008).
Peck, A. & Mellins, E. D. Precarious balance: Th17 cells in host defense. Infect. Immun. 78, 32–38 (2010).
Ahmad, D. S., Esmadi, M. & Steinmann, W. C. Idiopathic CD4 lymphocytopenia: spectrum of opportunistic infections, malignancies, and autoimmune diseases. Avicenna J. Med. 3, 37–47 (2013).
Hormaeche, C. E., Harrington, K. A. & Joysey, H. S. Natural resistance to salmonellae in mice: control by genes within the major histocompatibility complex. J. Infect. Dis. 152, 1050–1056 (1985).
Klein, C., Lisowska-Grospierre, B., LeDeist, F., Fischer, A. & Griscelli, C. Major histocompatibility complex class II deficiency: clinical manifestations, immunologic features, and outcome. J. Pediatr. 123, 921–928 (1993).
Dharmana, E. et al. HLA-DRB1*12 is associated with protection against complicated typhoid fever, independent of tumour necrosis factor α. Eur. J. Immunogenet. 29, 297–300 (2002).
Dunstan, S. J. et al. Genes of the class II and class III major histocompatibility complex are associated with typhoid fever in Vietnam. J. Infect. Dis. 183, 261–268 (2001).
Cummings, L. A., Barrett, S. L. R., Wilkerson, W. D., Fellnerova, I. & Cookson, B. T. FliC-specific CD4+ T cell responses are restricted by bacterial regulation of antigen expression. J. Immunol. 174, 7929–7938 (2005).
Lee, S.-J. et al. Temporal expression of bacterial proteins instructs host CD4 T cell expansion and Th17 development. PLoS Pathog. 8, e1002499 (2012).
Mastroeni, P., Villarreal-Ramos, B. & Hormaeche, C. E. Adoptive transfer of immunity to oral challenge with virulent salmonellae in innately susceptible BALB/c mice requires both immune serum and T cells. Infect. Immun. 61, 3981–3984 (1993).
Nanton, M. R., Way, S. S., Shlomchik, M. J. & McSorley, S. J. Cutting edge: B cells are essential for protective immunity against Salmonella independent of antibody secretion. J. Immunol. 189, 5503–5507 (2012).
Hermaszewski, R. A. & Webster, A. D. Primary hypogammaglobulinaemia: a survey of clinical manifestations and complications. Q. J. Med. 86, 31–42 (1993).
Winkelstein, J. A. et al. X-linked agammaglobulinemia: report on a United States registry of 201 patients. Medicine (Baltimore) 85, 193–202 (2006).
Levy, J., Espanol-Boren, T., Thomas, C. & Fischer, A. Clinical spectrum of X-linked hyper-IgM syndrome. J. Pediatr. 131, 47–54 (1997).
Fraser, A., Paul, M., Goldberg, E., Acosta, C. J. & Leibovici, L. Typhoid fever vaccines: systematic review and meta-analysis of randomised controlled trials. Vaccine 25, 7848–7857 (2007).
Feasey, N. A., Dougan, G., Kingsley, R. A., Heyderman, R. S. & Gordon, M. A. Invasive non-typhoidal salmonella disease: an emerging and neglected tropical disease in Africa. Lancet 379, 2489–2499 (2012).
Geldmacher, C. et al. Early depletion of Mycobacterium tuberculosis-specific T helper 1 cell responses after HIV-1 infection. J. Infect. Dis. 198, 1590–1598 (2008).
Dandekar, S., George, M. D. & Bäumler, A. J. Th17 cells, HIV and the gut mucosal barrier. Curr. Opin. HIV AIDS 5, 173–178 (2010).
MacLennan, C. A. et al. Dysregulated humoral immunity to nontyphoidal Salmonella in HIV-infected African adults. Science 328, 508–512 (2010).
Mastroeni, P., Grant, A., Restif, O. & Maskell, D. A dynamic view of the spread and intracellular distribution of Salmonella enterica. Nat. Rev. Microbiol. 7, 73–80 (2009).
Crump, J. A., Ram, P. K., Gupta, S. K., Miller, M. A. & Mintz, E. D. Part I. Analysis of data gaps pertaining to Salmonella enterica serotype Typhi infections in low and medium human development index countries, 1984–2005. Epidemiol. Infect. 136, 436–448 (2008).
Gordon, M. A. et al. Epidemics of invasive Salmonella enterica serovar Enteritidis and S. enterica serovar Typhimurium infection associated with multidrug resistance among adults and children in Malawi. Clin. Infect. Dis. 46, 963–969 (2008).
Crump, J. A. & Mintz, E. D. Global trends in typhoid and paratyphoid fever. Clin. Infect. Dis. 50, 241–246 (2010).
MacLennan, C. A., Martin, L. B. & Micoli, F. Vaccines against invasive Salmonella disease: current status and future directions. Hum. Vaccin. Immunother. 10, 1478–1493 (2014).
Pier, G. B. et al. Salmonella typhi uses CFTR to enter intestinal epithelial cells. Nature 393, 79–82 (1998).
van de Vosse, E. et al. Distribution of CFTR variations in an Indonesian enteric fever cohort. Clin. Infect. Dis. 50, 1231–1237 (2010).
Acknowledgements
The authors thank P. Mastroeni and D. Holden for their comments on the manuscript.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Competing interests
C.A.M. is the recipient of a clinical research fellowship from GlaxoSmithKline. J.J.G. and A.V.S.H. declare no competing interests.
Supplementary information
Supplementary information S1 (table)
Genetic variation resulting in invasive Salmonella susceptibility in humans and mice (PDF 356 kb)
Glossary
- Genome-wide association study
-
(GWAS). Hypothesis-free genetic association study that tests for associations between a trait of interest and variation at millions of single nucleotide polymorphisms across the genome.
- Candidate gene studies
-
Genetic case-control studies in which the exposure of interest is variation at a genetic locus chosen according to a prior biological hypothesis.
- Hypomorphic mutations
-
Mutations resulting in decreased function of the encoded protein.
- Ectodermal dysplasia
-
A genetically and phenotypically heterogeneous group of congenital disorders characterized by abnormal hair and teeth, and reduced perspiration.
- Hypermorphic mutations
-
Mutations that lead to increased function of the encoded protein.
- Missense mutation
-
Mutation resulting in an amino acid change in the encoded protein product.
- Nonsense mutation
-
Mutation resulting in a premature stop codon in the encoded transcript.
- Inflammasome
-
Cytosolic multi-protein complex composed of an innate pattern-recognition receptor, an adaptor molecule and a pro-inflammatory effector caspase.
- Pyroptosis
-
Pro-inflammatory programmed cell death, with cell lysis alongside pro-inflammatory cytokine release.
- Autophagy
-
Cellular process targeting cytoplasmic contents, including cytoplasmic pathogens, for lysosomal degradation via the formation of double-membraned, intracellular autophagosomes.
- Haematocrit
-
The proportion, by volume, of blood that is composed of red blood cells.
- Siderophores
-
High-affinity iron-binding molecules that facilitate the sequestration of iron by microorganisms.
- Hereditary haemochromatosis
-
Common autosomal recessive disorder characterized by iron overload and secondary organ dysfunction, most frequently caused by mutations in the HFE gene.
- Severe combined immunodeficiency
-
A group of congenital immunodeficiencies defined by deficient T cell, B cell and/or natural killer cell lineages.
- DiGeorge syndrome
-
Syndrome of hypoplastic thymus and parathyroid glands and congenital cardiac disease, caused by a 22q11.2 deletion.
- Imputation
-
Statistical estimation of genotype information not directly assayed, by inference from surrounding genotype data and densely genotyped reference panels.
- X-linked agammaglobulinaemia
-
Primary immunodeficiency secondary to mutations in Bruton's tyrosine kinase (BTK) resulting in defective B cell development with hypogammaglobulinaemia and reduced circulating B cells.
- X-linked hyper IgM syndrome
-
Primary immunodeficiency secondary to mutations in the CD4+ T cell surface-expressed molecule CD40 ligand (CD40LG; also known as CD154), resulting in defective B cell activation and isotype switching.
Rights and permissions
About this article
Cite this article
Gilchrist, J., MacLennan, C. & Hill, A. Genetic susceptibility to invasive Salmonella disease. Nat Rev Immunol 15, 452–463 (2015). https://doi.org/10.1038/nri3858
Published:
Issue Date:
DOI: https://doi.org/10.1038/nri3858
This article is cited by
-
Giant splenic cyst complicated by infection due to Salmonella enterica serovar Livingstone in a previously healthy adolescent male: a case report
BMC Infectious Diseases (2022)
-
Serotyping of sub-Saharan Africa Salmonella strains isolated from poultry feces using multiplex PCR and whole genome sequencing
BMC Microbiology (2021)
-
Characterization of fungal microbial diversity in healthy and diarrheal Tibetan piglets
BMC Microbiology (2021)
-
Geographical distribution of risk factors for invasive non-typhoidal Salmonella at the subnational boundary level in sub-Saharan Africa
BMC Infectious Diseases (2021)
-
Repurposing diphenylbutylpiperidine-class antipsychotic drugs for host-directed therapy of Mycobacterium tuberculosis and Salmonella enterica infections
Scientific Reports (2021)